Hideyasu Yamada

524 total citations
28 papers, 225 citations indexed

About

Hideyasu Yamada is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hideyasu Yamada has authored 28 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Hideyasu Yamada's work include Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Allergic Rhinitis and Sensitization (4 papers). Hideyasu Yamada is often cited by papers focused on Asthma and respiratory diseases (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Allergic Rhinitis and Sensitization (4 papers). Hideyasu Yamada collaborates with scholars based in Japan, Italy and China. Hideyasu Yamada's co-authors include Nobuyuki Hizawa, Tohru Sakamoto, Hironori Masuko, Yohei Yatagai, Emiko Noguchi, Takashi Naito, Satoshi Konno, Masaharu Nishimura, Hiroaki Iijima and Tomomitsu Hirota and has published in prestigious journals such as PLoS ONE, Clinical & Experimental Allergy and Respiratory Research.

In The Last Decade

Hideyasu Yamada

27 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideyasu Yamada Japan 10 155 116 58 35 34 28 225
Juan José Nieto‐Fontarigo Spain 13 210 1.4× 141 1.2× 71 1.2× 14 0.4× 92 2.7× 30 352
Arjun Ravi United Kingdom 7 97 0.6× 164 1.4× 105 1.8× 28 0.8× 12 0.4× 12 280
Brian Rector United States 4 207 1.3× 152 1.3× 69 1.2× 15 0.4× 35 1.0× 6 255
Griet Conickx Belgium 7 93 0.6× 124 1.1× 79 1.4× 21 0.6× 19 0.6× 9 357
Mandeep Hundal United States 3 61 0.4× 33 0.3× 96 1.7× 7 0.2× 10 0.3× 6 185
Andrzej Dyczek Poland 7 123 0.8× 64 0.6× 43 0.7× 23 0.7× 16 201
Anna Duckworth United Kingdom 7 44 0.3× 110 0.9× 29 0.5× 2 0.1× 6 0.2× 12 195
Ryuichi Togawa Japan 7 35 0.2× 71 0.6× 14 0.2× 2 0.1× 8 0.2× 22 159
Michael Williamson Ireland 4 11 0.1× 110 0.9× 19 0.3× 8 0.2× 5 0.1× 6 161
Fotis Psarros Greece 9 39 0.3× 17 0.1× 77 1.3× 13 0.4× 15 0.4× 14 227

Countries citing papers authored by Hideyasu Yamada

Since Specialization
Citations

This map shows the geographic impact of Hideyasu Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyasu Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyasu Yamada more than expected).

Fields of papers citing papers by Hideyasu Yamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyasu Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyasu Yamada. The network helps show where Hideyasu Yamada may publish in the future.

Co-authorship network of co-authors of Hideyasu Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyasu Yamada. A scholar is included among the top collaborators of Hideyasu Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyasu Yamada. Hideyasu Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyazaki, Kunihiko, et al.. (2023). Discontinuation of Immune Checkpoint Inhibitor due to irAEs in NSCLC Patients With EGFR Mutation. Cancer Diagnosis & Prognosis. 3(2). 244–250. 1 indexed citations
2.
Yamada, Hideyasu, Masayuki Nakajima, Masashi Matsuyama, et al.. (2021). Identification of distinct phenotypes related to benralizumab responsiveness in patients with severe eosinophilic asthma. PLoS ONE. 16(3). e0248305–e0248305. 14 indexed citations
4.
Masuko, Hironori, Jun Kanazawa, Hideyasu Yamada, et al.. (2020). ORMDL3/GSDMB genotype as a risk factor for early-onset adult asthma is linked to total serum IgE levels but not to allergic sensitization. Allergology International. 70(1). 55–60. 14 indexed citations
5.
Sato, Shinya, Hideyasu Yamada, Kunihiko Miyazaki, et al.. (2019). Rinsing of oropharynx and storage place of respiratory medicine inhaler: A cross‐sectional audit. Journal of General and Family Medicine. 20(3). 101–106. 1 indexed citations
6.
Watanabe, Hiroko, Hideyasu Yamada, Shinya Sato, et al.. (2019). Application of Cluster Analysis to Distant Metastases from Lung Cancer. Anticancer Research. 40(1). 413–419. 3 indexed citations
7.
Watanabe, Hiroko, Hideyasu Yamada, Shinya Sato, et al.. (2019). The Prognosis of Lung Cancer With Different Metastatic Patterns. Anticancer Research. 40(1). 421–426. 2 indexed citations
8.
Satoh, Hiroaki, Kunihiko Miyazaki, Toshihiro Shiozawa, Hideyasu Yamada, & Tomohiro Tamura. (2018). Pattern of bone metastasis in patients with nonsmall cell lung cancer. Annals of Thoracic Medicine. 13(4). 257–257. 1 indexed citations
9.
Kanazawa, Jun, Hironori Masuko, Yohei Yatagai, et al.. (2018). Association analyses of eQTLs of the TYRO3 gene and allergic diseases in Japanese populations. Allergology International. 68(1). 77–81. 7 indexed citations
10.
Yamada, Hideyasu, et al.. (2018). Improved outcomes with pembrolizumab treatment in two cases of double cancer including non-small-cell lung cancer. Anti-Cancer Drugs. 30(1). 105–109. 5 indexed citations
11.
Inui, Toshihide, et al.. (2017). A case of a pulmonary artery sling misdiagnosed as refractory asthma for 20 years. Clinical Case Reports. 5(6). 863–866. 4 indexed citations
12.
Kanazawa, Jun, Hironori Masuko, Yohei Yatagai, et al.. (2017). Genetic association of the functional CDHR3 genotype with early-onset adult asthma in Japanese populations. Allergology International. 66(4). 563–567. 18 indexed citations
13.
Yamada, Hideyasu, Hironori Masuko, Yohei Yatagai, et al.. (2016). Role of Lung Function Genes in the Development of Asthma. PLoS ONE. 11(1). e0145832–e0145832. 10 indexed citations
14.
Iijima, Hiroaki, Hideyasu Yamada, Yohei Yatagai, et al.. (2014). [Effects of thymic stromal lymphopoietin (TSLP) genotypes on asthma phenotypes defined by the atopy cluster -influence of smoking habits-].. PubMed. 63(1). 33–44. 1 indexed citations
15.
Iijima, Hiroaki, Yoshiko Kaneko, Hideyasu Yamada, et al.. (2013). A Distinct Sensitization Pattern Associated with Asthma and the Thymic Stromal Lymphopoietin (TSLP) Genotype. Allergology International. 62(1). 123–130. 10 indexed citations
16.
Yatagai, Yohei, Tohru Sakamoto, Hironori Masuko, et al.. (2013). Genome-Wide Association Study for Levels of Total Serum IgE Identifies HLA-C in a Japanese Population. PLoS ONE. 8(12). e80941–e80941. 27 indexed citations
17.
Masuko, Hironori, Tohru Sakamoto, Hiroaki Iijima, et al.. (2013). Asthma Phenotypes in Japanese Adults - Their Associations with the CCL5 ADRB2 Genotypes. Allergology International. 62(1). 113–121. 37 indexed citations
18.
Yamada, Hideyasu, Wataru Ishii, Satoshi Ito, et al.. (2007). Sarcoid myositis with muscle weakness as a presenting symptom. Modern Rheumatology. 17(3). 243–246. 5 indexed citations
19.
Yamada, Hideyasu & N Hayashi. (2004). Implicit Solution of the Landau-Lifshitz-Gilbert Equation by the Crank-Nicolson Method. Journal of the Magnetics Society of Japan. 28(8). 924–931. 3 indexed citations
20.
Yamada, Hideyasu & N Hayashi. (2004). Solution of Landau-Lifshitz-Gilbert Equation by Newton's Method. Journal of the Magnetics Society of Japan. 28(3). 305–311. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026